Fetal Monitoring Market Size & Share, by Method (Invasive, Non-Invasive); End user; Product; Portability; Application - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2026-2035

  • Report ID: 4864
  • Published Date: Aug 25, 2025
  • Report Format: PDF, PPT

Fetal Monitoring Market Outlook:

Fetal Monitoring Market size was valued at USD 6.3 billion in 2025 and is projected to reach USD 11.4 billion by the end of 2035, growing at a CAGR of around 7% during the forecast period, i.e., 2026 to 2035. In 2026, the industry size of fetal monitoring is assessed at USD 6.7 billion.

The market is remarkably growing on account of increased awareness of maternal & neonatal health and increasing rates of high-risk pregnancies. Also, the continued technological advancements are an asset of this landscape that are transforming care with enhanced accuracy. As per an April 2025 WHO article, more than 700 women died each day from preventable pregnancy and childbirth-related causes in 2023, with a maternal death occurring nearly every two minutes. The report also stated that Most of these deaths are avoidable with proper medical care, denoting the necessity for fetal monitoring systems.

Furthermore, the revolutionary digital transformation in healthcare is yet another factor that is contributing to the fetal monitoring solution beyond hospital settings. Therefore, the study by AMA in May 2024 observed that remote postpartum blood pressure monitoring led to a 43% increase in achieving normal BP and a 56% rise in BP checks within 20 days of discharge. The report also highlighted that hypertensive disorders affect 16% of pregnancies in the U.S., and 31.6% of delivery-related deaths involve such conditions, highlighting the urgent need for early intervention and remote care solutions.

Fetal Monitoring Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF


Fetal Monitoring Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

7%

Base Year Market Size (2025)

USD 6.3 billion

Forecast Year Market Size (2035)

USD 11.4 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Fetal Monitoring Market Segmentation:

Method Segment Analysis

Based on the method, the non-invasive segment is projected to garner the largest revenue share of 76.4% in the fetal monitoring market during the forecast tenure. The safety standards, patient comfort, and reduced risk of complications are the key factors behind this proprietorship. In March 2023, researchers from Washington University introduced a non-invasive tool called electro myometrial imaging (EMMI) to visualize uterine contractions in 3D. This was funded by NIH, and the technology maps contraction patterns during labor, which enables better labor management and preterm birth care, hence a wider scope.

End user Segment Analysis

In terms of end user hospitals/maternity hospitals segment is growing at a considerable rate with a share of 68.4% in the market by the end of 2035. The settings handle a high volume of deliveries and high-risk pregnancies with advanced monitoring technologies, allowing a steady business flow. Therefore, in June 2025, Yashoda Hospital highlighted a protocolised, multi-system care framework for managing complex obstetric cases, which is a collaborative model that integrates intensivists, cardiologists, and other specialists to anticipate and address complications early.

Product Segment Analysis

Based on the product, the ultrasound devices segment is anticipated to gain a significant share of 52.6% in the fetal monitoring market during the discussed timeframe. The segment’s growth originates from a shift towards non-invasive prenatal care that includes advanced 3D or 4D imaging enhances diagnostic clarity. For instance, in November 2022, Philips introduced its Ultrasound Compact System 5000 Series at RSNA, which is designed to bring first-time-right diagnosis to reach out wider audience group. Also, the compact unit offers premium image quality in a portable form, making it ideal for point-of-care use.

Our in-depth analysis of the market includes the following segments:

Segment

Subsegments

Method

  • Invasive
  • Hospitals / Maternity Hospitals
  • Non-Invasive
  • Clinics

End user

  • Hospitals / Maternity Hospitals
  • Clinics
  • Home Care Settings / Others

Product

  • Ultrasound Devices
  • 2D ultrasound
  • 3D and 4D ultrasound
  • Doppler imaging
  • Electronic Fetal Monitors
  • Uterine Contraction Monitors
  • Portable Systems
  • Non-Portable Systems
  • Accessories & Consumables
  • Other Products

Portability

  • Portable Systems
  • Non-Portable Systems

Application

  • Antepartum Fetal Monitoring
  • Hospitals / Maternity Hospitals
  • Intrapartum Fetal Monitoring
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.


Fetal Monitoring Market - Regional Analysis

North America Market Insights

North America in the fetal monitoring market is expected to grow by capturing the largest revenue share of 40.7% by the end of 2035. This upliftment is readily propelled by the widespread adoption of medical technologies and a robust healthcare ecosystem. Therefore, NIH in September 2023 introduced a USD 2 million RADx Tech Fetal Monitoring Challenge to promote innovation in point-of-care and home-based fetal diagnostic technologies, which was sponsored by NIBIB, NICHD, and the Bill & Melinda Gates Foundation. The key emphasis is to improve fetal health outcomes, particularly in low-resource settings.

In the U.S., the fetal monitoring industry has become the key component in terms of both prenatal and perinatal care, which is extensively supported by a huge network of medical facilities. In this regard, UNICEF in May 2025 reported that it is supporting CareNX Innovations in expanding AI-driven fetal monitoring to ensure that no mother or baby is left behind due to a lack of access to quality care. The report also highlighted CareNX’s flagship product called Fetosense, which is a portable, AI-powered fetal monitoring system designed to enable early detection of fetal concerns, especially in underprivileged areas, hence benefiting the overall market.

Canada in the fetal monitoring market is displaying notable growth that benefits from the presence of a universal healthcare system, deliberately emphasizing preventive care and maternal health services. In June 2024, Clarius Mobile Health reported that it received FDA clearance for its Clarius OB AI, an AI-powered fetal biometric measurement tool integrated with its handheld Clarius C3 HD3 ultrasound scanner. The product is exclusively designed to automate critical obstetric calculations such as fetal age, weight, and growth, hence a positive market outlook.

Maternal and Infant Health Initiatives, Resources, and Key Data

Initiative / Resource

Year(s)

Key Focus / Data Points

MIHI Webinar Series

May-Aug 2024

Maternal mental health, substance use disorder (SUD), hypertension control, AIM bundles

Affinity Groups

Fall 2024

Maternal mental health & SUD; maternal hypertension & cardiovascular health

Maternal Health Infographic

2024

Medicaid covers ~42% of US births; 2/3 of adult women on Medicaid are of reproductive age (19 to 44)

Source: Medicaid

APAC Market Insights

Asia Pacific in the fetal monitoring market is considered to be the fastest-growing region due to the growing awareness about maternal and fetal health. Also, there have been remarkable improvements in healthcare infrastructure, which in turn increases the adoption of advanced medical technologies, thereby making it suitable for standard market upliftment. Furthermore, the region also benefits from a rapidly growing consumer base and an increasing number of hospitals and maternity care centers focusing on prenatal care.

China is also witnessing robust advancements in its healthcare sector, which is positively impacting the market. The country’s enhanced government and private sector activities are providing an encouraging opportunity to capitalize on this sector. Shenzhen Luckcome Technology Inc., Ltd., in May 2023, announced that it will participate in CMEF 2023, and will showcase its newly launched Jaundice Detector, which is portable and easy to use, comprising a unique pressure calibration algorithm, and can store 20 sets of data.

India in the market has become the targeted hub due to the significant government initiatives that are readily propelling a profitable business environment. In October 2024, MOH&FW reported that the country’s government, under the National Health Mission, implements various programs to improve maternal and child health, especially for underserved communities. The report also underscored that tribal areas benefit from relaxed norms for setting up health facilities, deploying ASHAs, and operating Mobile Medical Units with a special focus on high-risk pregnancies, early child care, immunization, and healthcare access in remote and tribal regions.

Europe Market Insights

Europe in the fetal monitoring market is immensely supported by the well-established healthcare systems and widespread adoption of advanced prenatal technologies with a supportive regulatory framework. In September 2024, St. Vincent’s Private Hospital declared that it entered into a 10-year, €40 million Value Partnership with Siemens Healthineers, which marks the first-of-its-kind collaboration in Ireland’s private healthcare sector. Besides, this partnership enhances care by integrating with advanced AI technologies to enhance diagnostic and treatment capabilities.

The U.K. holds a strong position in the fetal monitoring sector that is proactively shaped by National Health Service protocols and guidelines that standardize care across the country. The pioneers in the country are also putting constant efforts to strengthen the ecosystem extremely supported emphasis on personalized maternity care. In September 2024, Comen introduced CF5/CF8 Fetal and Maternal Monitors, which are especially designed for advanced, stable, and streamlined monitoring. Also, they are equipped with intelligent algorithms that minimize false alarms due to fetal movement and feature a detailed CTG scoring system based on seven clinical criteria.

Germany is gaining traction in the market, which is both robust and technologically advanced, facilitated by widespread adoption. In July 2022, Siemens Healthineers stated that at the European Congress of Radiology, it unveiled its most comprehensive ultrasound portfolio, which features 12 new transducers across four ultrasound systems called Acuson Sequoia, Redwood, Juniper, and P500, along with major software enhancements and expanded AI-powered tools.  Hence, such moves contribute to the steady demand for fetal monitoring equipment in the country.

Fetal Monitoring Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Key Fetal Monitoring Market Players:

    The international market of fetal monitoring is extremely consolidated, wherein the pioneers GE Healthcare and Philips are leading through AI-based innovations and telehealth partnerships. Meanwhile, the firms from the U.S. and Europe are dominating by emphasizing premium-priced devices, whereas the Asia-based organizations, such as Edan and Trismed, are targeting the cost-sensitive markets. On the other hand, Japan’s industry is deliberately focusing on precision ultrasound and hospital integration, hence suitable for standard market growth.

    Below is the list of some prominent players operating in the global market:

    Company Name

    Country

    Market Share (2024)

    Industry Focus

    GE Healthcare

    U.S.

    18.9%

    Non-invasive monitors, AI-powered ultrasound (e.g., Voluson series).

    Philips Healthcare

    Netherlands

    15.4%

    Wireless fetal monitors, telehealth integration (e.g., Avalon FM20).

    Edan Instruments

    China

    8.6%

    Portable Dopplers, low-cost monitoring solutions for emerging markets.

    Siemens Healthineers

    Germany

    7.4%

    Advanced CTG systems, EHR-compatible devices (e.g., Sonoline Fetal Monitors).

    Natus Medical

    U.S.

    5.6%

    Neonatal & fetal monitoring (e.g., NicoletOne).

    Medtronic

    Ireland

    xx%

    Invasive monitoring tools, IoT-enabled platforms.

    Huntleigh Healthcare

    UK

    xx%

    Hospital-grade fetal Dopplers (e.g., MiniDopp series).

    Analogic Corporation

    U.S.

    xx%

    Ultrasound imaging systems for high-risk pregnancies.

    ArjoHuntleigh

    Sweden

    xx%

    Mobile fetal monitors for home care.

    Trismed

    India

    xx%

    Affordable fetal ECG devices (e.g., Trismed Fetal Monitor).

    Bionet

    South Korea

    xx%

    AI-based fetal heart rate analysis (e.g., BFM-6500).

    Mindray

    China

    xx%

    Portable monitors for rural clinics (e.g., M9 Ultrasound).

    Comen

    China

    xx%

    OEM supplier for fetal Dopplers and accessories.

    Cure Medical

    Malaysia

    xx%

    Disposable fetal monitoring sensors for intrapartum care.

    Monarch Meditech

    Australia

    xx%

    Telehealth-compatible fetal monitors for remote areas.

    Below are the areas covered for each company in the market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Recent Developments

  • In September 2024, Raydiant Oximetry, Inc. reported that it had secured a USD 1 million grant from the Bill & Melinda Gates Foundation to advance its Lumerah technology. It has a non-invasive fetal pulse oximeter that aims to improve the detection of fetal distress during childbirth.
  • In February 2024, GE HealthCare announced that it received FDA 510(k) clearance for its Novii Wireless Maternal and Fetal Monitoring Solution, which is currently approved for use in approximately 95% of eligible U.S. births. The device productively tracks fetal heart rate, maternal heart rate, and uterine activity for patients at ≥34 weeks of gestation.
  • Report ID: 4864
  • Published Date: Aug 25, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the fetal monitoring market was over USD 6.3 billion.

The market size for the Fetal Monitoring market is projected to reach USD 11.4 billion by the end of 2035, expanding at a CAGR of 7% during the forecast period, i.e., between 2026-2035.

The major players in the market are GE Healthcare, Philips Healthcare, Edan Instruments, Siemens Healthineers, Natus Medical, and others.

In terms of method, the noninvasive segment is anticipated to garner the largest market share of 76.4% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 40.7% by the end of 2035 and provide more business opportunities in the future.
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.


Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos